- Home
- EDIT vs ESGL Comparison
EDIT vs ESGL Comparison
Compare EDIT & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- ESGL
- Stock Information
- Founded
- EDIT 2013
- ESGL 1999
- Country
- EDIT United States
- ESGL Singapore
- Employees
- EDIT N/A
- ESGL N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- ESGL
- Sector
- EDIT Health Care
- ESGL
- Exchange
- EDIT Nasdaq
- ESGL Nasdaq
- Market Cap
- EDIT 115.5M
- ESGL 99.1M
- IPO Year
- EDIT 2016
- ESGL N/A
- Fundamental
- Price
- EDIT $1.79
- ESGL $2.38
- Analyst Decision
- EDIT Buy
- ESGL
- Analyst Count
- EDIT 13
- ESGL 0
- Target Price
- EDIT $6.73
- ESGL N/A
- AVG Volume (30 Days)
- EDIT 1.9M
- ESGL 44.2K
- Earning Date
- EDIT 05-12-2025
- ESGL 06-10-2025
- Dividend Yield
- EDIT N/A
- ESGL N/A
- EPS Growth
- EDIT N/A
- ESGL N/A
- EPS
- EDIT N/A
- ESGL N/A
- Revenue
- EDIT $35,837,000.00
- ESGL $6,099,784.00
- Revenue This Year
- EDIT N/A
- ESGL N/A
- Revenue Next Year
- EDIT N/A
- ESGL N/A
- P/E Ratio
- EDIT N/A
- ESGL N/A
- Revenue Growth
- EDIT N/A
- ESGL N/A
- 52 Week Low
- EDIT $0.91
- ESGL $0.90
- 52 Week High
- EDIT $6.22
- ESGL $3.00
- Technical
- Relative Strength Index (RSI)
- EDIT 60.00
- ESGL 64.57
- Support Level
- EDIT $1.70
- ESGL $2.06
- Resistance Level
- EDIT $1.95
- ESGL $2.44
- Average True Range (ATR)
- EDIT 0.15
- ESGL 0.18
- MACD
- EDIT 0.03
- ESGL 0.03
- Stochastic Oscillator
- EDIT 76.03
- ESGL 95.89
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.